China temporarily includes COVID-19 antigen tests in medical insurance
BEIJING -- China has brought antigen tests into its medical insurance as an interim measure against COVID-19, according to the National Healthcare Security Administration.
Such expenses occurred at designated grassroots medical institutions should be settled pursuant to existing provisions of social pooling units while the cost for antigen testing reagents at designated retail pharmacies can be covered by individual accounts, said the administration in a circular issued on Monday.
Provincial authorities should incorporate antigen testing reagents and corresponding tests into the service catalogue of their basic medical insurance, and continue to regulate the price of such services, added the circular.
They are also asked to cover the cost of newly added medicine in the latest version of diagnosis and treatment protocol for COVID-19 via their medical insurance funds.
- Chinese medical team undertakes volunteer mission in Ethiopia
- Chenbarhu Banner Grassland in Inner Mongolia dressed in autumn hues
- Environmental inspection teams release findings
- Liaison office of central govt spokesperson hails Macao SAR 8th Legislative Assembly election
- China discovers highest-altitude Qin Dynasty engraved stone on Qinghai-Tibet Plateau
- Traditional culture enthusiasts experience handicraft exchange at museum in China's Xinjiang
